Ex vivo assay to evaluate the efficacy of drugs targeting sphingolipids in preventing SARS-CoV-2 infection of nasal epithelial cells

This protocol enables the testing of drugs against infection of epithelial cells with SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2), using pseudo-typed replication deficient vesicular stomatitis virus particles (pp-VSV) presenting the SARS-CoV-2 spike protein. After treating human vol...

Descripción completa

Detalles Bibliográficos
Autores principales: Becker, Katrin Anne, Carpinteiro, Alexander, Hoffmann, Markus, Pöhlmann, Stefan, Kornhuber, Johannes, Gulbins, Erich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857112/
https://www.ncbi.nlm.nih.gov/pubmed/33558862
http://dx.doi.org/10.1016/j.xpro.2021.100356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857112/
https://www.ncbi.nlm.nih.gov/pubmed/33558862
http://dx.doi.org/10.1016/j.xpro.2021.100356

Ejemplares similares